Literature DB >> 2248619

Influence of serum triglycerides on the HDL pattern in normal subjects and patients with coronary artery disease.

L Calabresi1, G Franceschini, M Sirtori, G Gianfranceschi, P Werba, C R Sirtori.   

Abstract

The distribution and structure of high density lipoprotein (HDL) subfractions were examined by rate zonal ultracentrifugation in 200 consecutive subjects, 86 of whom showed a stable hypertriglyceridemia, 22 with coronary artery disease. Among the remaining 114 normotriglyceridemic subjects, 75 were healthy and 39 had coronary disease. The serum levels of the HDL2 subfraction were reduced by 22% in the 39 normotriglyceridemic coronary patients, and by 21% in the whole group of hypertriglyceridemic subjects. No difference in the HDL3 levels was found in any of the studied group. There was a clear negative correlation between HDL2 levels and triglyceridemia in the case of healthy people, not in coronary patients. By contrast, triglyceridemia was negatively correlated with the HDL3 flotation rate, both in healthy subjects and coronary patients at all triglyceride levels. Compositional data indicate that in hypertriglyceridemic subjects, HDL2 levels are reduced because of an enhanced transfer-exchanged process between the enlarged VLDL pool and HDL; in contrast, in coronary patients, a defective maturation of the HDL3 particle is the most likely underlying mechanism. Both in hypertriglyceridemic individuals, as well as in coronary patients, the HDL subfraction distribution is rather similar and drastically different from that of normotriglyceridemic healthy subjects. The mechanisms of the two conditions are probably different and, whereas a low concentration of HDL2 is definitely a major risk factor for normotriglyceridemic individuals, in the case of hypertriglyceridemics other factors may come into play in the final determination of the coronary risk.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2248619     DOI: 10.1016/0021-9150(90)90006-5

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

1.  Children with NAFLD are more sensitive to the adverse metabolic effects of fructose beverages than children without NAFLD.

Authors:  Ran Jin; Ngoc-Anh Le; Shuling Liu; Monica Farkas Epperson; Thomas R Ziegler; Jean A Welsh; Dean P Jones; Craig J McClain; Miriam B Vos
Journal:  J Clin Endocrinol Metab       Date:  2012-04-27       Impact factor: 5.958

2.  Deoxysphingolipids Upregulate MMP-1, Downregulate TIMP-1, and Induce Cytotoxicity in Human Schwann Cells.

Authors:  Richard L Klein; Andrea Semler; Samar Hammad; Maria F Lopes-Virella; Yan Huang
Journal:  Neuromolecular Med       Date:  2021-12-01       Impact factor: 4.103

3.  The distribution of o,p'-DDD (mitotane) among serum lipoproteins in normo- and hypertriglyceridemia.

Authors:  D O Gebhardt; A J Moolenaar; A P van Seters; E A van der Velde; J A Gevers Leuven
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Activity profile of gemfibrozil on the major plasma lipoprotein parameters.

Authors:  C R Sirtori; G Franceschini; G Gianfranceschi; V Vaccarino; G Chiesa; P Maderna; M Bertoli; L Calabresi
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

5.  Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin.

Authors:  Toshiyuki Hayashi; Tomoyasu Fukui; Noriko Nakanishi; Saki Yamamoto; Masako Tomoyasu; Anna Osamura; Makoto Ohara; Takeshi Yamamoto; Yasuki Ito; Tsutomu Hirano
Journal:  Cardiovasc Diabetol       Date:  2017-01-13       Impact factor: 9.951

6.  Association of High-Density Lipoprotein Subclasses with Carotid Intima-Media Thickness: Shimane CoHRE Study.

Authors:  Yoshitomo Notsu; Shozo Yano; Miwako Takeda; Masayuki Yamasaki; Minoru Isomura; Toru Nabika; Atsushi Nagai
Journal:  J Atheroscler Thromb       Date:  2017-04-27       Impact factor: 4.928

Review 7.  Pathophysiology of Diabetic Dyslipidemia.

Authors:  Tsutomu Hirano
Journal:  J Atheroscler Thromb       Date:  2018-07-12       Impact factor: 4.928

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.